chantal, Author at Scancell - Page 5 of 10

Notice of Results

by chantal | Sep 4, 2025 | Latest News, Regulatory News

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell reports Strong Phase 2 Data on iSCIB1+ in Advanced Melanoma

by chantal | Jul 24, 2025 | Immunobody, Investor Presentations, iSCIB1+

Successful SCOPE outcome and iSCIB1+ selection

by chantal | Jul 22, 2025 | iSCIB1+, SCIB1, Trinity Delta Reports

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Active Immunotherapy for a Cancer-Free Future

by chantal | Jul 22, 2025 | Immunobody, Investor Presentations, iSCIB1+, SCIB1

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody^® iSCIB1+

by chantal | Jul 22, 2025 | Latest News, News

« Older Entries

Next Entries »